Alto Neuroscience, Inc. (ANRO)
NYSE·Healthcare·Biotechnology
$24.39
+0.47%
Mkt Cap $783.30M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | — | — | — | -$0.56 | -$0.45 | +19.64% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.66 | -$0.52 | +21.21% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.57 | -$0.65 | -14.04% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.59 | -$0.53 | +10.17% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.65 | -$0.56 | +13.85% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.67 | -$0.62 | +7.46% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.71 | -$0.60 | +15.49% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.46 | -$0.76 | -65.22% | — | — |
| Q1 2024 Mar 21, 2024 | — | $372.00K | — | -$1.67 | -$7.77 | -365.27% | — | — |
| Q1 2024 Feb 5, 2024 | — | — | — | — | -$0.34 | — | — | — |
| Q2 2023 Jun 29, 2023 | — | — | — | — | -$0.32 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.27 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.30 | — | — | — |